CMV management in lung transplant recipients

E.M.A. Verschuuren (Groningen, The Netherlands)

Source: School Course 2012 - Lung Transplantation
Number: 25

Slide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E.M.A. Verschuuren (Groningen, The Netherlands). CMV management in lung transplant recipients. School Course 2012 - Lung Transplantation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009


Cytomegalovirus quantitative-PCR study in pulmonary tissue from lung transplant recipients
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016


Pulmonary complications in renal transplant recipients
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Prevalence of SDB in lung transplant recipients
Source: Breathe 2010; 6: 274
Year: 2010

Pre-habilitation in lung transplant candidates
Source: Short video discussion 2021
Year: 2021

Pulmonary complications in heart transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 181s
Year: 2004

Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Specificities of the paediatric lung transplant recipient
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Metapneumovirus pneumonia in allogeneic stemcell transplant recipients
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011

Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Expression of EGR in lung transplant recipients
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010


Outcomes of telehealth care for lung transplant recipients
Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century
Year: 2021


Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 347s
Year: 2002

Chronic respiratory complications in paediatric heart transplant recipients
Source: Eur Respir J 2006; 28: Suppl. 50, 311s
Year: 2006

Fatigue and functional capacity in kidney transplant recipients before and after transplant.
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017


How to perform a lung transplant
Source: School Course 2012 - Lung Transplantation
Year: 2012